| Literature DB >> 27308595 |
Sameer H Halani1, Daniel J Brat1.
Abstract
A recently published investigation by The Cancer Genome Atlas on lower grade diffuse gliomas provides biologic justification for defining diseases based on genetic properties rather than histologic features. Unsupervised clustering of data from multiple advanced molecular platforms divided diseases robustly into 3 cohesive groups that could be captured by clinically available biomarkers more reliably than by histology.Entities:
Keywords: Astrocytoma; TCGA; brain tumor; diffuse glioma; genetics; molecular profile; oligodendroglioma
Year: 2015 PMID: 27308595 PMCID: PMC4905393 DOI: 10.1080/23723556.2015.1074333
Source DB: PubMed Journal: Mol Cell Oncol ISSN: 2372-3556